Trident Lifeline (543616) Stock Overview
Manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
543616 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Trident Lifeline Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹250.00 |
| 52 Week High | ₹328.00 |
| 52 Week Low | ₹229.95 |
| Beta | -0.27 |
| 1 Month Change | -1.11% |
| 3 Month Change | 1.94% |
| 1 Year Change | -7.41% |
| 3 Year Change | 84.84% |
| 5 Year Change | n/a |
| Change since IPO | 131.16% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543616 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 3.7% | 0.5% | 3.8% |
| 1Y | -7.4% | 8.1% | 0.5% |
Return vs Industry: 543616 underperformed the Indian Pharmaceuticals industry which returned 8.1% over the past year.
Return vs Market: 543616 underperformed the Indian Market which returned 0.5% over the past year.
Price Volatility
| 543616 volatility | |
|---|---|
| 543616 Average Weekly Movement | 5.1% |
| Pharmaceuticals Industry Average Movement | 7.2% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
Stable Share Price: 543616 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543616's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 74 | Shravan Patel | tridentlifeline.com |
Trident Lifeline Limited, together with its subsidiaries, manufactures and markets finished doses in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally. The company offers various medicinal products, including pharmaceuticals, nutraceuticals, herbals, and injectables in the form of tablets, capsules, dry powders for oral suspension, oral liquids, ointments, liquid ointments, effervescent tablets, sachets, pastes, gels, solutions, suspensions, ice gels, syrups, and creams, as well as toothpaste and mouthwash. Its products target a range of therapeutic solutions, such as antibacterial, antidiarrheal, antifungal, antimalarial, antidiabetic, dental cure, proton pump inhibitor, antiprotozoal, antihistamine, antihypertensive drugs, antiparasitic, antilipidemic drugs, multivitamins, multiminerals, and non-steroidal anti-inflammatory drugs.
Trident Lifeline Limited Fundamentals Summary
| 543616 fundamental statistics | |
|---|---|
| Market cap | ₹2.96b |
| Earnings (TTM) | ₹190.41m |
| Revenue (TTM) | ₹1.29b |
Is 543616 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543616 income statement (TTM) | |
|---|---|
| Revenue | ₹1.29b |
| Cost of Revenue | ₹764.59m |
| Gross Profit | ₹525.63m |
| Other Expenses | ₹335.21m |
| Earnings | ₹190.41m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.96 |
| Gross Margin | 40.74% |
| Net Profit Margin | 14.76% |
| Debt/Equity Ratio | 67.7% |
How did 543616 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/18 18:17 |
| End of Day Share Price | 2026/06/18 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Trident Lifeline Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.